Answer
Breastfeeding must be avoided until one month after the last dose of Onivyde pegylated liposomal because of the potential for serious adverse reactions in breastfed infants.
Sources for this answer
- ONIVYDE pegylated liposomal 4.3 mg/ml concentrate for dispersion for infusionServier Laboratories Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 13Document updated
Sources checked